LEADER 01267nam  2200361Ia 450 
001 9910697068603321
005 20230902162156.0
035   $a(CKB)5470000002384214
035   $a(OCoLC)606590971
035   $a(EXLCZ)995470000002384214
100   $a20100412d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eantiviral product development, conducting and submitting virology studies to the agency
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2006]
215   $a1 online resource (14 pages)
300   $a"Clinical antimicrobial."
300   $a"June 2006."
517   $aGuidance for industry 
606   $aAntiviral agents$xDevelopment$zUnited States
606   $aVirology$xResearch$zUnited States
615  0$aAntiviral agents$xDevelopment
615  0$aVirology$xResearch
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697068603321
996   $aGuidance for industry$93434577
997   $aUNINA